After years of focusing on her large family, and three sons with Duchenne MD, columnist Betty Vertin is eager to reconnect with friends.

Researchers identified a molecular pathway that can limit muscle repair, a finding that may guide future muscular dystrophy treatments.

After following the Olympics, columnist Robin Stemple envisions a future with new treatments and even a cure for FSHD.

Roche has decided to stop developing satralizumab for bone health in Duchenne muscular dystrophy, the company announced.